Skip to content

China H-type Hypertension Registry Study

A Real World, Multi-centric, Observational Registry of H-type Hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017274
Enrollment
Unknown
Registered
2018-07-20
Start date
2018-07-14
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H-type Hypertension

Interventions

H-type hypertension population:Nil

Sponsors

Shenzhen Evergreen Medical Institute/ Anhui Medical University Biomedical Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older; 2. Hypertensive patients diagnosed according to ; 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Psychological or nervous system impairment resulting in an inability to demonstrate informed consent; 2. Unable to be followed-up according to the study protocol, or plans to relocate in the near future; 3. Those patients who are not suitable for inclusion or for long-term follow-up as assessed by study physicians.

Design outcomes

Primary

MeasureTime frame
The control rate of hypertension; BP Decrease; Hcy Decrease;;Stroke;

Secondary

MeasureTime frame
Compound cardio cerebrovascular events ( —Including nonfatal stroke, myocardial infarction, and vascular death);Myocardial infarction (Fatal/nonfatal);Ischemic stroke;Hemorrhagic stroke;Vascular death;All cause death;Tumor;All hospitalizations;

Contacts

Public ContactBinyan Wang, M.D

Shenzhen Evergreen Medical Institute

binyanwang163@163.com+86 15901363687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026